162 related articles for article (PubMed ID: 3755758)
1. Potential antitumor agents. 47. 3'-Methylamino analogues of amsacrine with in vivo solid tumor activity.
Atwell GJ; Baguley BC; Finlay GJ; Rewcastle GW; Denny WA
J Med Chem; 1986 Sep; 29(9):1769-76. PubMed ID: 3755758
[TBL] [Abstract][Full Text] [Related]
2. Potential antitumor agents. 40. Orally active 4,5-disubstituted derivatives of amsacrine.
Denny WA; Atwell GJ; Baguley BC
J Med Chem; 1984 Mar; 27(3):363-7. PubMed ID: 6546590
[TBL] [Abstract][Full Text] [Related]
3. Potential antitumor agents. 41. Analogues of amsacrine with electron-donor substituents in the anilino ring.
Atwell GJ; Rewcastle GW; Denny WA; Cain BF; Baguley BC
J Med Chem; 1984 Mar; 27(3):367-72. PubMed ID: 6546591
[TBL] [Abstract][Full Text] [Related]
4. Potential antitumor agents. 48. 3'-Dimethylamino derivatives of amsacrine: redox chemistry and in vivo solid tumor activity.
Atwell GJ; Rewcastle GW; Baguley BC; Denny WA
J Med Chem; 1987 Apr; 30(4):652-8. PubMed ID: 3560159
[TBL] [Abstract][Full Text] [Related]
5. Potential antitumor agents. 50. In vivo solid-tumor activity of derivatives of N-[2-(dimethylamino)ethyl]acridine-4-carboxamide.
Atwell GJ; Rewcastle GW; Baguley BC; Denny WA
J Med Chem; 1987 Apr; 30(4):664-9. PubMed ID: 3560161
[TBL] [Abstract][Full Text] [Related]
6. Potential antitumor agents. 52. Carbamate analogues of amsacrine with in vivo activity against multidrug-resistant P388 leukemia.
Rewcastle GW; Baguley BC; Atwell GJ; Denny WA
J Med Chem; 1987 Sep; 30(9):1576-81. PubMed ID: 3625706
[TBL] [Abstract][Full Text] [Related]
7. Potential antitumor agents. 42. Structure-activity relationships for acridine-substituted dimethyl phosphoramidate derivatives of 9-anilinoacridine.
Rewcastle GW; Atwell GJ; Baguley BC; Denny WA
J Med Chem; 1984 Aug; 27(8):1053-6. PubMed ID: 6747989
[TBL] [Abstract][Full Text] [Related]
8. Potential antitumor agents. 39. Anilino ring geometry of amsacrine and derivatives: relationship to DNA binding and antitumor activity.
Denny WA; Atwell GJ; Baguley BC
J Med Chem; 1983 Nov; 26(11):1625-30. PubMed ID: 6688830
[TBL] [Abstract][Full Text] [Related]
9. Potential antitumor agents. 38. 3-substituted 5-carboxamido derivatives of amsacrine.
Denny WA; Atwell GJ; Baguley BC
J Med Chem; 1983 Nov; 26(11):1619-25. PubMed ID: 6688829
[TBL] [Abstract][Full Text] [Related]
10. Synthesis, antitumor activity, and DNA binding properties of a new derivative of amsacrine, N-5-dimethyl-9-[(2-methoxy-4-methylsulfonylamino) phenylamino]-4-acridinecarboxamide.
Baguley BC; Denny WA; Atwell GJ; Finlay GJ; Rewcastle GW; Twigden SJ; Wilson WR
Cancer Res; 1984 Aug; 44(8):3245-51. PubMed ID: 6547635
[TBL] [Abstract][Full Text] [Related]
11. Potential antitumor agents. 49. 5-substituted derivatives of N-[2-(dimethylamino)ethyl]-9-aminoacridine-4-carboxamide with in vivo solid-tumor activity.
Denny WA; Atwell GJ; Rewcastle GW; Baguley BC
J Med Chem; 1987 Apr; 30(4):658-63. PubMed ID: 3560160
[TBL] [Abstract][Full Text] [Related]
12. Divergent activity of derivatives of amsacrine (m-AMSA) towards Lewis lung carcinoma and P388 leukaemia in mice.
Baguley BC; Kernohan AR; Wilson WR
Eur J Cancer Clin Oncol; 1983 Nov; 19(11):1607-13. PubMed ID: 6688994
[TBL] [Abstract][Full Text] [Related]
13. Potential antitumor agents. 46. Structure-activity relationships for acridine monosubstituted derivatives of the antitumor agent N-[2-(dimethylamino)ethyl]-9-aminoacridine-4-carboxamide.
Rewcastle GW; Atwell GJ; Chambers D; Baguley BC; Denny WA
J Med Chem; 1986 Apr; 29(4):472-7. PubMed ID: 3959026
[TBL] [Abstract][Full Text] [Related]
14. Cell line selectivity and DNA breakage properties of the antitumour agent N-[2-(dimethylamino)ethyl]acridine-4-carboxamide: role of DNA topoisomerase II.
Schneider E; Darkin SJ; Lawson PA; Ching LM; Ralph RK; Baguley BC
Eur J Cancer Clin Oncol; 1988 Nov; 24(11):1783-90. PubMed ID: 2850193
[TBL] [Abstract][Full Text] [Related]
15. Potential antitumor agents. 37. Organophosphorus derivatives of 9-anilinoacridine.
Rewcastle GW; Baguley BC; Cain BF
J Med Chem; 1982 Oct; 25(10):1231-5. PubMed ID: 7143362
[TBL] [Abstract][Full Text] [Related]
16. Potential antitumor agents. 35. Quantitative relationships between antitumor (L1210) potency and DNA binding for 4'-(9-acridinylamino)methanesulfon-m-anisidide analogues.
Baguley BC; Denny WA; Atwell GJ; Cain BF
J Med Chem; 1981 May; 24(5):520-5. PubMed ID: 6894620
[TBL] [Abstract][Full Text] [Related]
17. Comparison of antitumor properties of nitracrine and amsacrine analogs.
Mazerska Z; Chołody M; Lukowicz J; Wysocka-Skrzela B; Ledóchowski A
Arzneimittelforschung; 1987 Nov; 37(11):1276-81. PubMed ID: 3326605
[TBL] [Abstract][Full Text] [Related]
18. Chromophore-modified antineoplastic imidazoacridinones. Synthesis and activity against murine leukemias.
Cholody WM; Martelli S; Konopa J
J Med Chem; 1992 Jan; 35(2):378-82. PubMed ID: 1732555
[TBL] [Abstract][Full Text] [Related]
19. CI-921: an analog of amsacrine with experimental activity against solid tumors.
Grove WR; DeLap LW; Grillo-López AJ
Invest New Drugs; 1986; 4(2):113-8. PubMed ID: 3755424
[TBL] [Abstract][Full Text] [Related]
20. 2-(aminoalkyl)-5-nitropyrazolo[3,4,5-kl]acridines, a new class of anticancer agents.
Capps DB; Dunbar J; Kesten SR; Shillis J; Werbel LM; Plowman J; Ward DL
J Med Chem; 1992 Dec; 35(26):4770-8. PubMed ID: 1479579
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]